Treatment of Hypoglycemia in Type 1 Diabetes
Type 1 Diabetes
About this trial
This is an interventional treatment trial for Type 1 Diabetes focused on measuring Hypoglycemia, carbohydrates
Eligibility Criteria
Inclusion Criteria:
- Males and females ≥ 18 years of old.
- Clinical diagnosis of type 1 diabetes for at least one year.
- Treatment with multiple daily insulin injections or insulin pump therapy and using insulin analogs (rapid, ultra-rapid and basal).
- HbA1c ≤ 10%.
Exclusion Criteria:
- Clinically significant microvascular complications: nephropathy (estimated glomerular filtration rate below 40 ml/min), neuropathy (especially diagnosed gastroparesis) or severe proliferative retinopathy as judged by the investigator.
- Recent (< 3 months) acute macrovascular event e.g. acute coronary syndrome or cardiac surgery.
- Known significant cardiac rhythm abnormality based on investigator judgment.
- Abnormal blood panel and/or anemia (Hb < 100g/L).
- Ongoing pregnancy or breastfeeding.
- Severe hypoglycemic episode within 1 month of screening.
- Known uncorrected hypokalemia (potassium < 3.5 mmol/L; available within the past 3 months).
Sites / Locations
- Institut de recherches cliniques de Montréal
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Active Comparator
Active Comparator
Active Comparator
Active Comparator
16g of carbohydrates - Glucose levels < 3.0 mmol/L
16g of carbohydrates - Glucose levels 3.0-3.5 mmol/L
32g of carbohydrates - Glucose levels < 3.0 mmol/L
32g of carbohydrates - Glucose levels 3.0-3.5 mmol/L
Hypoglycemia treatment with 16g of carbohydrates will be given when glucose levels are below 3.0 mmol/L.
Hypoglycemia treatment with 16g of carbohydrates will be given when glucose levels are between 3.0 and 3.5 mmol/L.
Hypoglycemia treatment with 32g of carbohydrates will be given when glucose levels are below 3.0 mmol/L
Hypoglycemia treatment with 32g of carbohydrates will be given when glucose levels are between 3.0 and 3.5 mmol/L.